VSee Health (NASDAQ:VSEE) vs. Schrodinger (NASDAQ:SDGR) Critical Contrast

VSee Health (NASDAQ:VSEE) and Schrodinger (NASDAQ:SDGR) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, analyst recommendations, institutional ownership, risk and valuation.

Profitability

This table compares VSee Health and Schrodinger’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
VSee Health	-92.36%	-11,636.34%	-68.62%
Schrodinger	-20.98%	-16.37%	-8.19%

Analyst Recommendations

This is a breakdown of current ratings and price targets for VSee Health and Schrodinger, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
VSee Health	1	0	0	0	1.00
Schrodinger	1	2	4	1	2.62

Schrodinger has a consensus price target of $25.50, suggesting a potential upside of 12.83%. Given Schrodinger’s stronger consensus rating and higher probable upside, analysts clearly believe Schrodinger is more favorable than VSee Health.

Earnings and Valuation

This table compares VSee Health and Schrodinger”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
VSee Health	$14.46 million	0.47	-$14.71 million	($0.37)	-5.08
Schrodinger	$259.04 million	6.44	-$103.26 million	($0.74)	-30.54

VSee Health has higher earnings, but lower revenue than Schrodinger. Schrodinger is trading at a lower price-to-earnings ratio than VSee Health, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

1.0% of VSee Health shares are held by institutional investors. Comparatively, 79.1% of Schrodinger shares are held by institutional investors. 14.9% of VSee Health shares are held by insiders. Comparatively, 10.1% of Schrodinger shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Schrodinger beats VSee Health on 10 of the 14 factors compared between the two stocks.

About VSee Health

VSee Health, Inc. is a no-code or low-code software as a service (SaaS) platform that enables clinicians and enterprises to create their telehealth workflows without programming. It engages in providing timely, quality healthcare to patients regardless of geographical barriers. The company is headquartered in Boca Raton, FL.

About Schrodinger

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.